perifosine

Aeterna Zentaris to Discontinue Phase 3 Trial in Multiple Myeloma with Perifosine Following Data Safety Monitoring Board Recommendation

Aeterna Zentaris to Discontinue Phase 3 Trial in Multiple Myeloma with Perifosine Following Data Safety Monitoring Board Recommendation

Yahoo

4 Small Biotechs With Big Clinical Trials Presenting In 2013

4 Small Biotechs With Big Clinical Trials Presenting In 2013

Seeking Alpha

Aeterna Zentaris: Late-Stage Drug Candidates Could Send Stock Higher

Aeterna Zentaris: Late-Stage Drug Candidates Could Send Stock Higher

Seeking Alpha

AEterna Zentaris' Pipeline Giving It A Lift As A Bottom Bounce Trade

AEterna Zentaris' Pipeline Giving It A Lift As A Bottom Bounce Trade

Seeking Alpha

Here We Go Again With AEterna Zentaris... Again

Here We Go Again With AEterna Zentaris... Again

Seeking Alpha

ASCO '12: Colon Cancer Drugs Good (Roche) and Very Bad (Keryx Pharma)

ASCO '12: Colon Cancer Drugs Good (Roche) and Very Bad (Keryx Pharma)

The Street

Biotech Hot Potato: Perifosine

Biotech Hot Potato: Perifosine

Motley Fool

Keryx: Still Better Than Big Pharma

Keryx: Still Better Than Big Pharma

Motley Fool

Keryx: Few Options After Failed Trial

Keryx: Few Options After Failed Trial

Seeking Alpha

Keryx: Lessons From a Drug Failure

Keryx: Lessons From a Drug Failure

TheStreet.com